Table 2. In Vitro Cytotoxicity of Analogs (10–24) Against the HCT-116/L Cell Line.
| compounds | R3 | R4 | R5 | R6 | GI50(nM) |
|---|---|---|---|---|---|
| 10 | CH3 | H | H | H | 141 ± 27 |
| 11 | H | CH3 | H | H | 30 ± 5 |
| 12 | H | H | CH3 | H | 24 ± 5 |
| 13 | H | H | H | CH3 | 16 ± 3 |
| 14 | H | F | H | H | 7 ± 1 |
| 15 (FC116) | H | H | F | H | 6 ± 1 |
| 16 | H | Cl | H | H | 17 ± 2 |
| 17 | H | Br | H | H | >10000 |
| 18 | H | NO2 | H | H | 71 ± 5 |
| 19 | H | H | NO2 | H | 15 ± 1 |
| 20 | H | H | H | NO2 | 24 ± 3 |
| 21 | H | H | NH2 | H | 27 ± 3 |
| 22 | H | H | OCH3 | H | 47 ± 2 |
| 23 | H | H | COOCH3 | H | 151 ± 19 |
| 24 | H | H | COOH | H | >10000 |
| oxaliplatin | 77213 ± 2041 | ||||
